Regeneron's Best-Selling Eye Drug Eylea's Higher Dose Formulation Meets Primary Goal In...

Regeneron's EYLEA HD met key goals in the Phase 3 QUASAR trial for macular edema after retinal vein occlusion, with FDA submission expected in Q1 2025.  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

A message from our valued partners and today's trending news.

Regeneron's Best-Selling Eye Drug Eylea's Higher Dose Formulation Meets Primary Goal In Another Form Of Retinal Disease Study Regeneron's EYLEA HD met key goals in the Phase 3 QUASAR trial for macular edema after retinal vein occlusion, with FDA submission expected in Q1 2025. More Info ➔ Who wants a pig organ? Patients sick and tired of waiting years for a transplant LOUISVILLE, Ky. (AP) — The calls and emails started coming into and soon after doctors began experimenting with pig organs in humans. More Info ➔ Elon Musk: "This Is the Most Destructive Force in History" - Ad Elon Musk claims a terrifying new economic force will put millions of Americans out of work. The ripple effects could nudge the US economy into a catastrophic tailspin. If this happens, you need to be prepared. That's why a former Trump advisor is sharing his contingency plan with the public. What is Musk talking about? Get the full details now. SolarEdge Poised For Growth Amid Cost Cuts, While Canadian Solar Faces US Policy Headwinds: Goldman Sachs Goldman Sachs analyst Brian Lee revised ratings for residential solar stock, upgrading SolarEdge and downgrading Canadian Solar due to policy risks. More Info ➔ Americans end 2024 with grim economic outlook, but Republicans are optimistic for 2025: AP-NORC poll WASHINGTON (AP) — The and the but Democrats are feeling more pessimistic about the U.S. economy after , according to a new poll. More Info ➔ This under-the-radar company is primed for an incredible year! - Ad Every week we reveal diamonds in the rough, under-the-radar stocks so make sure you don't miss out! Text STOCKS to (833) 861-1388. Get today's top stock White Sox shorten ballpark's name to Rate Field CHICAGO (AP) — The Chicago White Sox are changing the name of their ballpark. A change in luck can't be guaranteed. More Info ➔ New Meme Coin From Shiba Inu Ecosystem Up For Grabs: Here's How Much SHIB, LEASH, BONE Holders Can Expect The Shiba Inu (CRYPTO: SHIB) ecosystem announced an exclusive airdrop of its newly launched meme coin Shifu (SHIFU) on Monday to reward its loyal community members. More Info ➔ 4 Fastest Growing Blue Chip Stocks - Ad Blue chip stocks can be an ideal addition to your portfolio if you are risk-averse. These companies enjoy a favorable reputation and historic stability in the markets. Based on the latest activity, these 4 blue chip stocks have been gaining fast. Get The Top Stocks By clicking the link above you will automatically opt-in to receive emails from SystemTrading and agree to Privacy Policy Christmas Movie With The Rock Flops At Box Office, Breaks Streaming Records For This Company A Christmas movie that struggled at the box office will turn into a hit for the parent company thanks to a strong streaming debut. More Info ➔ US retreats from massive air bag recall and says industry comments show need for more investigation DETROIT (AP) — U.S. auto safety regulators have backed away from seeking a giant recall of nearly 50 million air bag inflators and will investigate further after the auto industry raised questions about whether all of the inflators are defective. More Info ➔ How a Tiny 1% Use a Secret Whale CashFlow Strategy That Pays in Down Markets - Ad How do you beat the market and earn while everyone else loses? You get paid without trading it. It's true. Using a legit "loophole" that only 1% of people in crypto even know about, you can actually get paid when other people trade. More Info ➔ Biden calls for ban on congressional stock trading WASHINGTON (AP) — President endorsed a ban on congressional stock trading in an interview that’s being released this week, belatedly weighing in on an issue that has been debated on Capitol Hill for years. More Info ➔ What's Going On With Illumina Stock On Monday? Illumina exits Nasdaq-100, reports Q3 EPS of $1.14 beating estimates, faces macroeconomic challenges, and lowers 2024 revenue guidance. More Info ➔ Youngkin proposes tax relief on tips and cars in his adjusted Virginia budget plan RICHMOND (AP) — Virginia Gov. Glenn Youngkin proposed a state budget plan on Wednesday to provide tax relief on tips and cars, measures his Republican administration touted as giving money back to middle- and lower-income workers. More Info ➔ Jim Cramer Signals Potential Bottom For Nvidia At $127 After Predicting 'Vicious' Reversal Earlier Jim Cramer suggested on Tuesday that NVIDIA Corp. may have reached a key turning point after the stock touched $127, potentially signaling a bottom for the semiconductor giant's recent pullback. More Info ➔ Grassroots funding for Ukraine's military declines as groups looks for creative ways to raise money KYIV, Ukraine (AP) — The concert took place in an old movie studio in Kyiv, the location kept secret until the final moment in case it was the target of a . More Info ➔ Fashion influencer Matilda Djerf apologizes following report she created a toxic workplace A popular social media influencer has issued an apology after a Swedish tabloid published a report saying she created a “work environment filled with fear and psychological pressure” at her fashion brand, Djerf Avenue. More Info ➔

Information, charts or examples contained in this email are for illustration and educational purposes only and not for individualized investment management. This message contains commercial elements, such as advertising as well as partner offers for which we may receive affiliate compensation. We only send these offers to those who have opted in to our newsletter. If you wish to no longer receive these offers click on the unsubscribe link at the bottom of this email. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained in this email or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault. 339-20 De Boers Dr., Toronto, ON M3J 0H1, 917.672.7040 © 2024 Musth | TrendAdvisor | All rights reserved. Unsubscribe

Share on Facebook

Share on Twitter

Share on Google+

Share on LinkedIn

Subscribe to receive free email updates: